Optimark and Regular insulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Optimark (gadoversetamide) and Regular insulin (insulin pork). Common drug interactions include injury among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Optimark and Regular insulin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Regular insulin?

Regular insulin has active ingredients of insulin pork. It is often used in type 1 diabetes. eHealthMe is studying from 2,848 Regular insulin users. Check the latest studies of Regular insulin.



On Jul, 26, 2026

13 people who take Optimark and Regular insulin together, and have interactions are studied.

Optimark and Regular insulin drug interactions.

What are the common drug interactions of Optimark and Regular Insulin, by gender? *:

female:

  1. Injury
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Pain
  4. Activities of daily living impaired
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Emotional distress
  8. Joint range of motion decreased (disease of joint movement)
  9. Mobility decreased (ability to move is reduced)
  10. Pruritus (severe itching of the skin)

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Pain
  3. General physical health deterioration (weak health status)
  4. Injury
  5. Muscle contracture (a permanent shortening of a muscle)
  6. Scar
  7. Asthma
  8. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  9. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Optimark and Regular Insulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Asthma
  3. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  4. Depression
  5. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  6. Fatigue (feeling of tiredness)
  7. Joint contracture (a permanent shortening of a muscle or joint)
  8. Joint stiffness
  9. Memory impairment
  10. Mobility decreased (ability to move is reduced)

40-49:

n/a

50-59:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Pain
  3. Anxiety
  4. Emotional distress
  5. Mobility decreased (ability to move is reduced)
  6. Skin induration (an abnormally hard spot or area on the skin)
  7. Skin hypertrophy (skin cells enlarges)
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Depression
  10. Gait disturbance

60+:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  3. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  4. Oedema peripheral (superficial swelling)
  5. Pain
  6. Peau d'orange (orange peel skin)
  7. Skin hyperpigmentation (disorders affect the colour of your skin)
  8. Skin hypertrophy (skin cells enlarges)
  9. Skin tightness

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Brain: 6 people, 46.15%
  2. High Blood Pressure: 6 people, 46.15%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 46.15%
  4. Diabetes: 6 people, 46.15%
  5. Pain: 5 people, 38.46%
  6. Eye Disorder: 5 people, 38.46%
  7. Sleep Disorder: 4 people, 30.77%
  8. Analgesia: 2 people, 15.38%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
  10. Intraocular Pressure Increased: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and Regular insulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Optimark and Regular insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Optimark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Regular insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Optimark and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Regular insulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gadoversetamide and insulin pork (the active ingredients of Optimark and Regular insulin, respectively), and Optimark and Regular insulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: